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Summary
Peri-operative partial arterial oxygen tension (Pao.z)
was monitored in 20 patients undergoing total hip
replacement. Three distinct groups emerged on
analysis of the arterial oxygen tensions.
In group I there was no initial decrease in Pao.z but
it rose above baseline level towards the end of the
procedure. In group 11 there was a distinct fall in
Pa~during the acetabularand femoral stages of the
operation. On termination of the procedure Pa~
had returned to baseline levels. In group '" Pa~
values were significantly lower than those in group
11 during the acetabular and femoral stages and
decreased further at the end of the procedure. One
patient in group 11 and 6 in group III developed
postoperative pulmonary dysfunction.
A progressive deterioration in P~ during hip
replacement without recovery at end of the proee-
. dure indicates that the patient is likely to develop
postoperative pulmonary dysfunction.
S At, Med J 1982; 82: 1027-1029.
A report by Sprouleel aV in 1964 was the first to elucidate some
aspects of the fat embolism syndrome. In 1966 Ashbaugh and
Petty2 demonstrated the pathological changes which take place
in the respiratory distress syndrome, which has since been shown
to be the common denominator in conditions such as shock lung
and micropulmonary embolism.
It is not universally agreed that the presence of fat in the
pulmonary circulation is of clinical significance in the fat embo-
lism syndrome. Many investigators believe that the syndrome is
caused by platelet aggregation and fibrin deposition in the lungs,
initiated by tissue thromboplastin release. 3
Peltier reported a 5,5% mortality directly related to fat embo-
lism in a large series of trauma patients.4 At autopsies carried out
in the Birmingham Accident Hospital, pulmonary fat embolism
was observed in 44% of patients who had died of severe skeletal
trauma.5
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Patients undergoing intramedullary prosthetic hip surgery are
prone to develop the fat embolism syndrome.6 We investigated
such a group of patients to gain further information about this
disorder.
Patients and methods
Patients
Twenty patients with no history of major systemic illness and
undergoing total hip replacement for osteo-arthritis under gen-
eral anaesthesia were studied. The mean age of the group (±SD)
was 69 ± 9 years (range 53-94 years).
Anaesthetic management
Patients were given premedication oflorazepam or a combina-
tion of pethidine hydrochloride and promethazine hydrochlo-
ride, the former being favoured for older patients. Mter they had
been given oxygen for 4 minutes anaesthesia was induced with
thiopentone 1-2 mg/kg, followed by alcuronium 0,25 mg/kg.
They were ventilated with an inspired oxygen fraction of 0,4 in
nitrous oxide. The trachea was sprayed with 4% lignocaine and a
number 8 or 9 cuffed endotracheel tube was inserted. Approp-
riate doses of diazepam and!or fentanyl and a low concentration
of enflurane « 1,0%) was used for maintenance of anaesthesia.
Ventilation was with a Bird Mk II-Ventviva combination incor-
porating a warm-water humidifier. Expired carbon dioxide was
monitored with a Godart infant capnograph and kept at normal
levels. At the end of the operation curarization was reversed with
atropine and prostigmine.
Postoperatively the patients were exposed to an inspired oxy-
gen fraction of 0,4 for 24 hours, using a Ventimask.
Monitoring
A 20G radial artery catheter was inserted and arterial and
mean arterial pressures were monitored continuously, using an
AE 840 pressure transducer and Simonsen and Weel oscillo-
scope and digital display.
A central venous line was inserted via a basilic vein. Routine
chest radiography to confirm the position of the catheter was not
carried out. A swing of at least 1 cm H20 with respiration was
taken as reasonable evidence of central placement. Pulse, ECG
and temperature were also monitored continuously.
Surgical procedure
Routine total hip replacement by the Chamley method, with
partial excision of the joint capsule and trochanteric osteotomy,
was performed. Mter preparation of the acetabulum, acrylic
cement was inserted and the acetabular prosthesis fixed in posi-
tion. Care was taken not to insert the acrylic cement until it was
pliable, to minimize absorption offree acrylic monomers into the
Fig. 2. Measurement times: 2 - ± 30 minutes stable anaesthesia;
3 - ± 5 minutes after fixation of the acetabular prosthesis; 4 - ±
5 minutes after fixation of the femoral prosthesis; 5 - end of the
operation.
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circulation.7 The medullary cavity of the femur was reamed and
vented before insertion of the cement. The femoral prosthesis
was fixed in position in the medullary cavity. The trochanter of
the femur was reanached with steel wires. The mean duration of
the operation (±SD) was 125 ± 34 minutes and mean blood loss
was 900 ± 400 ml.
Measurement times
Blood samples were withdrawn at measurement times 1-7
(Fig. 1). The results for the sample taken at measurement time 6
were not used because of the effects of opiates on partial anerial
carbon dioxide tension (PacD:!) and inadequate control of the
inspired oxygen fraction. Note that the inspired oxygen fraction
varied at the different times.
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difference (P < 0,01) in comparison with group I. At point 5 the
PaD:! reached the baseline level. One patient developed pulmo-
nary dysfunction.
Group Ill. This group consisted of 7 patients. At m.easuring
times 3 and 4 the Pa02 was even lower than in group 11. The PaD:!
at position 5 was markedly lower, the difference from the group
11 value being highly significant (P> 0,0025). In this group 6 of
the 7 patients developed pulmonaty dysfunction.
In the 20 patients there was therefore a 35% incidence of
pulmonary dysfunction.
Fig. 1. Measurement times: 1 - pre-operative; 2 - ± 30 ITIinutes
stable anaesthesia; 3 - 5 minutes after fixation of the acetabular
prosthesis; 4 -5 minutes after fixation of the femoral prosthesis;
5 - end of operation; 6 -± 3 hours after the operatiQn; 7 - ± 24
hours after the operation.
Measurements performed
All estimations were on arterial blood samples. Anerial oxy~
gen tension (Pa02 ), PacD:! and pH were determined with a Gas-
Check AVL apparatus.
Results
Pa02
Because the patients were elderly and there was a wide range in
alveolar-anerial oxygen tension differences,s there was a large
scatter of results for the individual patients. It was therefore
decided to express changes in PaD:! as a percentage from control
values at measurement time 2, which reflected 'steady-state'
anaesthesia. Utilizing the results of measuring times 2-5, i.e. all
anaesthetic results, three distinct groups emerged (Fig. 2).
Group I. This group consisted of6 patients. No fail in PaD:! at
measuring times 3 and 4 (when the acetabulum and femur
respectively were operated on) and 5 (end of operation) was
demonstrated. On the contrary, at points 3-5 the PaD:! was higher
than the baseline level at point 2. No patient developed pulmo-
nary dysfunction9 or required treatment; these served as the
control group.
Group ll. This group consisted of 7 patients. At measuring
times 3 and 4 (depicting acetabular and femoral procedures
respectively) there was a distil}ct fall in PaD:!, which was more
severe at point 4. At both these points there was a highly significant
Paco2 and pH
There was no significant difference in these parameteFS at any
ofthe measuring times in the different groups, indicating a stable
anaesthetic state and adequate pulmonary ventilation.
Other haemo4ynami~param~ters
'fb:~ i!I1~rial pr\;s&l!f{! remained consrapt except for occasional
IWft9f f1y€mi!iio~§ {~"l§j JI1mlIg) ~ter the insertion of the
cel!1<;nt This is in llgr~~m~nt With other findings.lO,ll It appears
t~at ~<; u§~ of methylm~t4acrylateonly gives rise to minor
411ell19gYflllglic chang~s w~~4 are of spon duration.
In ~ll~f PilQents ther~ W~~ a tendency for the central venous
pressure (CVP) tQ f¥l wpile the D~>nes were operated on, and
more intravenous fluid, th!lIl appeared necessary was required to
keep the CVP stable. This is in agFel;~ent wiih the haemody-
namic changes demonstrated by Modig and Malmberg.6
Discussion
Postoperatively the patients were given an inspired oxygen frac-
tion of 0,4 for 24 hours. Blood pressure, pulse, temperature and
colour were carefully monitored. Patients were examined twice
daily.
Clinical features of the fat embolism syndrome (possibly syn-
onymous with pulmonary dysfunction) usually present on the
2nd postoperative day. Gurd and Wilsonl2 presented elaborate
criteria for detecting the fat embolism syndrome. We preferred
our simpler criteria to detect pulmonary dysfunction.
The usual panern is that the patient appears well on a post-
operative visit. On the next visit he or she complains ofshortness
of breath and 'feeling out of sons'. Examination reveals the
following: (i) tachypnoea (> 20/min); (ii) tachycardia (>
llD/min); (iii) Pao2 significantly lower than the pre-operative
level (P> 0,0125) - in our patients those who did not develop
pulmonary dysfunction showed no significant difference between
TABLE I. PERCENTA~E CHANGE FROM CONTROL
VALUES AT MEASURE~ENTTIME 5 IN GROUP III
PATIENTS WHO DEVE!-QPE[) PULMONARY
DYSFUf\lCTION
pre- and postoperative Pa02values; and (iv) Pac~ values at the
lower limits of normal, but not significantly different from the
pre-operative level. A raised temperature is not a feature, clinical
examination of the lungs is negative, and chest radiography
reveals no abnormalities.
These patients were then subjected to a 24-hour period of
oxygen inhalation at an inspired oxygen fraction of0,4, vigorous
chest physiotherapy and frequent blood gas estimations. In 6 of
the 7 patients who developed pulmonary dysfunction the Pa02
had returned to normal after 24 hours. In 1patient this result was
achieved in 48 hours.
We know that the fat embolism syndrome progresses to 'shock
lung', and owing to early diagnosis and prompt treatment none
of our patients died and morbidity was very low.
Studies by Modig's group3,13,14 have shown that major trauma
involving the femoral bone marrow results in immediate release
of tissue thromboplastin products. These thromboplastin pro-
ducts generate platelet and fibrin deposits on the venous side of
the systemic circulation and on the precapillary side of the
pulmonary circulation. The micro-emboli are then trapped in
the pulmonary microcirculation, which acts as a filter. It was also
demonstrated that the magnitude of tissue thromboplastin
release and pulmonary micro-embolism correlates well with the
severity of pulmonary dysfunction and hypoxaemia.3,9,14
In the presence of a normally functioning fibrinolytic system
there is rapid resolution of these micro-emboli, and if there are
pulmonary changes they will be transient.6 Our group I results
conform to this category, since none of these patients developed
hypoxaemia.
Modig and his co-workers6,13 found that 6 out of 7 patients in
their general anaesthetic group developed hypoxaemia which
was completely reversed within 30 minutes after impaction of the
femoral prosthesis. These results correlate well with those in our
group 11 patients.
A prolonged release of thromboplastic products, such as
occurs in severe tissue damage, leads to a continuous deposition
of micro-emboli in the lungs. If llt the same time the fibrinolytic
process is compromised, micro~mboliare retained in the pul-
monary microvasculature.15,16 Our group III patients appear to
fall into this category.
Modig and Malmberg6 found no correlation between the
reduction in Pao2after insertion of the femoral prosthesis and the
postoperative Pa~; our 6 patients in group III who developed
pulmonary dysfunction, however, showed a significant differ-
ence (P> 0,0125) between the pre-operative and postoperative
P302 (measuring tiilles 1 and 7), as well as a positive correlation
between Pa~ at insertion of the femoral prosthesis and after the
operation (points 4 and 7).
Modig and Malmberg6 have demonstrated a ventilation/per-
fusion defect in patients developing the fat embolism syndrome,
Patient
No.
3
5
13
14
15
16
Change from
control values
(%)
69
81
79
67
73
79
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and state that at an early stage of pulmonary dysfunction deter-
mination of the Pao2is the most valuable investigation. The very
significant difference between the mean Pa~ (P < 0,0025) in
group 11 and group III at measuring time 5 implies that this
single measurement can be used as a criterion to determine
which patients are at risk ofdeveloping postoperative pulmonary
dysfunction. From the Pao2data at measurement time 5 (Table
I) for the patients in group III who developed pulmonary dys-
function, the highest Pa~, seen in patient 5, was 81%of the mean
control value. Although our series is small, we conclude that if
the Pao2 at measurement time 5 is 18% or more lower than the
value during a stable anaesthetic state at measurement time 2, the
patient is at high risk of developing pulmonary dysfunction.
Conclusion
From our studies, the baseline Pa~ at measurement time 2 and
the Pao2at the end of the operation (measurement time 5) appear
to have prognostic implications. In relation to control values
(point 2) a reduction in Pao2of 18% or more at point 5 indicates
that the patient is at high risk ofdeveloping pulmonary dysfunc-
tion. These patients should be carefully monitored and treated at
the earliest indication oflung dysfunction. When following such
a regimen we experienced very low morbidity and no mortality.
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